Brokerages see the acquisition as aligned with Coforge's stated ambition to shift more deeply into higher-value, AI-driven ...

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

December 26, 2025 A newly released clinical review is drawing attention within medical and regulatory communities by consolidating available evidence on the side-effect profile of a widely prescribed ...

Immatics has innovative TCR therapies, strong cash position, and expanding clinical pipeline targeting solid tumors. Read for ...

U.S. President Donald Trump said on social media that the "powerful and deadly" strikes in the state of Sokoto were carried ...

Investing.com -- Neurosense Therapeutics Ltd (NASDAQ:NRSN) stock rose 5.5% on Monday after the company reported positive safety data for its Alzheimer’s disease treatment candidate.

Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...

Discover groundbreaking advancements in urologic oncology, including new standards for prostate, kidney, and bladder cancer ...

Burry is the kind of outspoken outcast who makes for a good character in a Michael Lewis book: a neurologist by training who ...

Some studies point to melatonin use as beneficial to heart health, while others say the opposite. Here’s how to make sense of ...

Trump, Musk, and Swift lead the world's most Googled figures, reflecting US dominance in politics and entertainment.

At a time when President Donald Trump’s administration is threatening retribution against cities and states that don’t ...